Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks

Plasma transfusion is indicated for replenishment of coagulative proteins to stop or prevent bleeding. In 2014, the Netherlands switched from using ~300mL fresh frozen plasma (FFP) units to using 200mL Omniplasma, a solvent/detergent treated pooled plasma (SD plasma), units. We evaluated the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Saadah, Nicholas H., Schipperus, Martin R., Wiersum-Osselton, Johanna C., van Kraaij, Marian G., Caram-Deelder, Camila, Beckers, Erik A.M., Leyte, Anja, Rondeel, Jan M.M., de Vooght, Karen M.K., Weerkamp, Floor, Zwaginga, Jaap Jan, van der Bom, Johanna G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109716/
https://www.ncbi.nlm.nih.gov/pubmed/31273090
http://dx.doi.org/10.3324/haematol.2019.222083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109716/
https://www.ncbi.nlm.nih.gov/pubmed/31273090
http://dx.doi.org/10.3324/haematol.2019.222083

Ejemplares similares